PIA
BLUE

Piedmont Investment Advisors’s bluebird bio BLUE Stock Holding History

Piedmont Investment Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-212
Closed -$431K – 986
2019
Q1 		$431K Buy
212
+3
+1% +$5.28K 0.02% 595
2018
Q4 		$269K Hold
209
– – 0.01% 788
2018
Q3 		$394K Buy
+209
New +$432K 0.02% 638
2018
Q2 		– Hold
0
– – – 2728

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Piedmont Investment Advisors's BLUE Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 212 shares — an estimated $431K sold.

Piedmont Investment Advisors first reported a position in BLUE in Q3 2018 and held it in 3 quarters. The position peaked at $431K in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 212 bluebird bio shares in Q2 2019, an estimated $431K.
  • Piedmont Investment Advisors first reported a position in bluebird bio in Q3 2018 and held it in 3 quarters.
  • Piedmont Investment Advisors's bluebird bio position peaked at $431K in Q1 2019.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.